Homocystein, Liquorparameter und Apolipoprotein E bei Demenzerkrankungen und leichter kognitiver Störung
Year: 2010
Type: dissertation
Study design: Observational Study
Abstract: 1. Background and Scope There remains considerable uncertainty about the role of homocysteine in the pathophysiology of dementia, and a potential causal link has been proposed, but not convincingly demonstrated. The primary goal of this study is an analysis of the relationships between plasma homocysteine and the Alzheimer specific cerebrospinal fluid (CSF) parameters total tau (t-tau), phospho-tau (p-tau), Aβ42 und Aβ40, with a view toward the etiological function of homocysteine in the genesis of dementia. Potential predictors of increased homocysteine levels are studied, such as ApoE genotype, coronary heart disease, diabetes mellitus, hyperlipidemia and arterial hypertension. Furthermore, the relationships between cognitive abilities and homocysteine levels, CSF parameters and ApoE genotype are investigated. 2. Methods (Patients, Study Parameters) We recruited 88 patients at the gerontopsychiatric centres in Erlangen, Göttingen and Bonn. For these patients, plasma homocysteine, CSF parameters (t-tau, p-tau 181, Aβ1-42, Aβx-42 and Aβx-40), vitamin B12, folic acid, creatinine, cholesterol and TSH were measured. In addition, genetic (apolipoprotein E), socio-demographic and cognitive parameters (mini-mental-state test) and the occurrence of coronary heart disease, diabetes mellitus, hyperlipedemia and arterial hypertension were recorded. Each patient was assigned to one of the following diagnostic groups: Alzheimer’s disease (AD; N=32), other dementia (Demenz-andere; N=8), mild cognitive impairment (LKS) as prodrominal phase of AD (LKS-AD; N=26), and LKS of other etiologies (LKS-andere; N=22). 3. Results Among non-carriers of the ApoE4 allele, homocysteine levels correlate negatively with t-tau (r = - 0.37, p = 0.04) and p-tau 181 (r = - 0.38, p = 0.04), and positively with the Aβ1-42 / Aβ40 quotient (r = 0.41, p = 0.03). Similar patterns arise among patients with Alzheimer specific etiology, patients with LKS and patients with a syndrome of dementia, and in the full sample. Arterial hypertension (p = 0.04), diabetes mellitus type 2 (p = 0.04) and coronary heart disease (p = 0.01) are significant predictors of homocysteine levels. ApoE genotype is also a predictor, with homocysteine levels for ε4 carriers projected to be about 2μmol/l higher than for non-carriers (p = 0.03). Among ε4 carriers, the proportion of patients with hyperhomocysteinemia (29.2 %) is twice that among non-carriers (14.7 %). In addition to vitamin B12 (r = -0.30; p = 0.001) and folic acid (r = - 0.41; p < 0.001), education shows a significant negative correlation (r = -0.33; p = 0.002) with homocysteine levels. 4. Conclusions Our results illustrate the multi-faceted dependencies between homocysteine levels and clinical, genetic and socio-demographic parameters. The extant neuropathologic literature has established a negative relationship between vascular components and neurodegenerative pathologies, after adjusting for dementia levels, and there is evidence that the extent of the neurodegenerative lesions is being reflected in the concentrations of the respective CSF markers. The negative association between homocysteine and t-tau and p-tau 181, respectively, and the positive correlation between homocysteine and Aβ1-42 / Aβ40, thus support the hypothesis that increased homocysteine levels as vascular risk factors, respectively markers of vascular pathology correspond to stronger vascular and lesser neurodegenerative components of the disease. This view of homocysteine is also supported by its relationships with diabetes mellitus and arterial hypertension, and with the atherosclerotic risk factor ApoE4
Author: Florian Günther
Institution: Friedrich-Alexander-Universität Erlangen-Nürnberg
Language: German
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: homocysteine, dementia, Alzheimer's disease, mild cognitive impairment, apolipoprotein E, APOE ε4, cerebrospinal fluid biomarkers, tau protein, amyloid-beta, plasma homocysteine, vitamin B12, folic acid, coronary artery disease, diabetes mellitus, hyperlipidemia, hypertension, cognitive impairment, geriatric psychiatry
Open Access status: green
OpenAlex ID: W7047767586
